about
Chromosome arm-specific long telomeres: a new clonal event in primary chronic myelogenous leukemia cells.Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.Telomere biology of human hematopoietic stem cells.Effects of PCB126 and PCB153 on telomerase activity and telomere length in undifferentiated and differentiated HL-60 cells.Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells.The importance of the telomere and telomerase system in hematological malignancies.T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.Telomeres: prognostic markers for solid tumors.Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cellsTelomere and telomerase in stem cells.Telomere biology of pediatric cancer.Disruption of Survivin in K562 cells elevates telomerase activity and protects cells against apoptosis induced by the Bcr-abl kinase inhibitor STI571.Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma.Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.Targeting telomerase in hematologic malignancy.Cancer stem cells and cancer therapy.Telomere dysfunction and its role in haematological cancer.Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells.Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.Telomere dysfunction and inactivation of the p16(INK4a)/Rb pathway in pyothorax-associated lymphoma.Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia.Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal.Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.Dysregulated expression of the major telomerase components in leukaemic stem cells.Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.Telomere dysfunction and chromothripsis.Telomere dynamics in childhood leukemia and solid tumors: a follow-up study.High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.
P2860
Q35042990-51F08C02-1C4C-4AA8-BA9E-E016D92A0B6EQ35643026-A5FCEF95-EF89-486C-B38A-39791970A33FQ35692612-3842FCCF-8F09-412A-AF7C-321E07A6DF24Q35761843-D574F6D3-EE8E-4D59-A235-4F3E84DA2CE7Q35821436-0448B9DA-468A-46EA-B635-ED2B57CD1EB5Q36221550-6D218201-850A-473D-8E29-AEEBAC2AA3E5Q36250927-73C0D726-6C9C-4B08-94BB-51461CF0E684Q36542887-39487B9A-1517-409C-B36C-D0F72B137683Q36615837-12EDC733-19E6-4007-B68F-66F23E2070C7Q36758330-7DD8B868-C3B2-4C85-95FB-F53573676C13Q36832376-389D45C7-1996-4786-9BE8-47D0CEA2F92FQ37010048-DA957FFF-6550-4D97-B368-FE237DB9B349Q37449688-B7E6E3EE-8B86-4533-BE4B-5CA78C8B1DBCQ37682984-C2D975A2-7021-49FF-B6E8-5CBA10D2AE34Q37750789-496283D0-D245-428D-9C72-58BBBEAA7278Q37841186-B9BFEBFC-1260-4D78-8ABE-7019A5C69AC3Q37974664-22999F1C-765A-4F0A-B90A-075A4DB87D98Q38342295-5A1A1131-947A-4064-A83F-CFA80807EC1AQ39556740-1CB0048B-BA09-4186-AAE0-102A073255C9Q39776035-40E8C48D-B67B-4A04-BDCA-998841283779Q40146902-F4FD39F9-C6A3-4AFB-9541-4543DF8588F1Q40170116-8B08129D-009C-4C68-8350-EF0BE071EF57Q40284074-DC28BC8C-DF40-43FE-9176-C7B75D354EC0Q40315553-25FB9F75-719B-401F-833C-26E6C42EA081Q40464802-2EBFE374-32D2-4E37-9A3A-6366E0C2968BQ40662526-95CFA54C-6FD5-42A8-A8CD-073F82D3905BQ44549002-FDE053F8-48D3-4966-912C-EE32F088BF19Q45270392-E86241F1-862E-4F32-B46A-2D3B15E38374Q46615370-D0D6EFF5-5270-410D-9A1C-FE6A202BBEF4Q47612537-70B4F2F0-1244-49FC-8C28-484B36B0E90FQ48922014-A7226515-A2A1-4990-9E17-ED0503607577Q52109001-5EDA4866-49AE-4E35-93D9-0E5030B32CB5Q53325736-03B90B49-5312-47B9-B8E6-7723E4980121Q54338593-12601BBE-820B-42A2-9525-30CAECE1F32C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Telomeres and telomerase in hematologic neoplasia.
@ast
Telomeres and telomerase in hematologic neoplasia.
@en
Telomeres and telomerase in hematologic neoplasia.
@nl
type
label
Telomeres and telomerase in hematologic neoplasia.
@ast
Telomeres and telomerase in hematologic neoplasia.
@en
Telomeres and telomerase in hematologic neoplasia.
@nl
prefLabel
Telomeres and telomerase in hematologic neoplasia.
@ast
Telomeres and telomerase in hematologic neoplasia.
@en
Telomeres and telomerase in hematologic neoplasia.
@nl
P2093
P2860
P356
P1433
P1476
Telomeres and telomerase in hematologic neoplasia.
@en
P2093
Goro Sashida
Junko H Ohyashiki
Tetsuzo Tauchi
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205075
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1004599470